VentriPoint Diagnostics
Focus: VentriPoint Diagnostics is a public cardiovascular diagnostics company specializing in ejection fraction measurement technology for heart disease assessment. The company operates a focused, device-based business model in the cardiac imaging space.
Profile data last refreshed 9h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About VentriPoint Diagnostics
AI assessmentNot HiringNo open roles listed right now. Follow VentriPoint Diagnostics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from VentriPoint Diagnostics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
1 imminent
ELEPSIA XR
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
LOE Approaching
Help build intelligence for VentriPoint Diagnostics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.